Switch to:
GuruFocus has detected 2 Warning Signs with Progenics Pharmaceuticals Inc $PGNX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Progenics Pharmaceuticals Inc (NAS:PGNX)
EV-to-EBITDA
37.95 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Progenics Pharmaceuticals Inc's enterprise value is $461.14 Mil. Progenics Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $12.15 Mil. Therefore, Progenics Pharmaceuticals Inc's EV/EBITDA ratio for today is 37.95.

PGNX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -132.8   Max: 233.2
Current: 37.99

-132.8
233.2

During the past 13 years, the highest EV/EBITDA Ratio of Progenics Pharmaceuticals Inc was 233.20. The lowest was -132.80. And the median was -2.90.

PGNX's EV-to-EBITDA is ranked lower than
68% of the 281 Companies
in the Global Biotechnology industry.

( Industry Median: 18.28 vs. PGNX: 37.99 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Progenics Pharmaceuticals Inc's stock price is $7.67. Progenics Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $0.10. Therefore, Progenics Pharmaceuticals Inc's P/E Ratio for today is 76.70.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Progenics Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=461.137/12.15
=37.95

Progenics Pharmaceuticals Inc's current Enterprise Value is $461.14 Mil.
Progenics Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -4.964 (Jun. 2016 ) + 36.565 (Sep. 2016 ) + -4.454 (Dec. 2016 ) + -14.997 (Mar. 2017 ) = $12.15 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Progenics Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=7.67/0.1
=76.70

Progenics Pharmaceuticals Inc's share price for today is $7.67.
Progenics Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -0.08 (Jun. 2016 ) + 0.52 (Sep. 2016 ) + -0.11 (Dec. 2016 ) + -0.23 (Mar. 2017 ) = $0.10.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Progenics Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda -8.47-4.34-1.81-1.9817.68-2.34-6.15103.98-9.1634.05

Progenics Pharmaceuticals Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda 103.98103.99179.87-6.95-9.16-5.90-6.9327.5834.0548.16
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK